6/4/2013

The FDA has granted Relievant Medsystems investigational device exemption to conduct a larger clinical study of its Intracept basivertebral nerve ablation device. The 200-participant trial will be expanded to include 20 U.S. clinical sites, where the device will be tested for treating recurrent low back pain.

Related Summaries